Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure

Ulrich P. Jorde, Pierre V. Ennezat, Jay Lisker, Vanarani Suryadevara, Jason Infeld, Sonja Cukon, Adam Hammer, Edmund H. Sonnenblick, Thierry H. Le Jemtel

Research output: Contribution to journalArticlepeer-review

186 Scopus citations

Fingerprint

Dive into the research topics of 'Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure'. Together they form a unique fingerprint.

Medicine & Life Sciences